Astrazeneca plc ADR (NASDAQ: AZN) kicked off on Monday, down -0.29% from the previous trading day, before settling in for the closing price of $68.93. Over the past 52 weeks, AZN has traded in a range of $60.47-$76.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 16.24%. While this was happening, its average annual earnings per share was recorded 11.79%. With a float of $3.10 billion, this company’s outstanding shares have now reached $3.10 billion.
Let’s determine the extent of company efficiency that accounts for 89900 employees.
Astrazeneca plc ADR (AZN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Astrazeneca plc ADR is 0.03%, while institutional ownership is 15.97%.
Astrazeneca plc ADR (AZN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 11.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.20% during the next five years compared to 17.72% growth over the previous five years of trading.
Astrazeneca plc ADR (NASDAQ: AZN) Trading Performance Indicators
Take a look at Astrazeneca plc ADR’s (AZN) current performance indicators. Last quarter, stock had a quick ratio of 0.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.65. Likewise, its price to free cash flow for the trailing twelve months is 22.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.91, a number that is poised to hit 0.97 in the next quarter and is forecasted to reach 4.63 in one year’s time.
Technical Analysis of Astrazeneca plc ADR (AZN)
Looking closely at Astrazeneca plc ADR (NASDAQ: AZN), its last 5-days average volume was 7.29 million, which is a jump from its year-to-date volume of 6.25 million. As of the previous 9 days, the stock’s Stochastic %D was 71.96%. Additionally, its Average True Range was 1.06.
During the past 100 days, Astrazeneca plc ADR’s (AZN) raw stochastic average was set at 86.04%, which indicates a significant increase from 68.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.47% in the past 14 days, which was lower than the 19.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $65.93, while its 200-day Moving Average is $66.63. However, in the short run, Astrazeneca plc ADR’s stock first resistance to watch stands at $69.35. Second resistance stands at $69.96. The third major resistance level sits at $70.37. If the price goes on to break the first support level at $68.33, it is likely to go to the next support level at $67.92. Should the price break the second support level, the third support level stands at $67.31.
Astrazeneca plc ADR (NASDAQ: AZN) Key Stats
The company with the Market Capitalisation of 213.09 billion has total of 3,100,411K Shares Outstanding. Its annual sales at the moment are 45,811 M in contrast with the sum of 5,955 M annual income. Company’s last quarter sales were recorded 12,024 M and last quarter income was 960,000 K.
